P-021 - ANALYSIS AND LESSONS LEARNED FROM A RT INCIDENT REPORTING SYSTEM

P-022 - ANALYSIS LOCAL INCIDENT REPORTING SYSTEM. IMPACT ON PATIENT SAFETY.

P-023 - ANALYSIS OF QUALITY FACTORS IN THE TREATMENT OF LUNG SBRT

P-024 - ANALYSIS OF THE MANAGEMENT OF ENDOMETRIAL CANCER IN OUR DEPARTMENT

P-025 - ANDROGEN RECEPTOR TARGETED THERAPY IN PROSTATE CANCER: OUR EXPERIENCE

P-026 - APALUTAMIDA EN PACIENTES CON CÁNCER DE PRÓSTATA METASTÁSICO HORMONOSENSIBLE

P-027 - APALUTAMIDE-TDA+RT/SBRT. NEW STANDARD OF CARE IN MHSPC OLIGOMETASTATIC?

P-028 - AREAS OF SECURITY IMPROVEMENT IMPLEMENTED AFTER ANALYSIS OF REPORTED INCIDENTS

P-029 - ARTIFICIAL INTELLIGENCE APPLIED TO AN AUTOMATIC BONE MARROW CONTOURING DESIGN.

P-030 - ASSESSING RADIATION DOSE FOR POSTOPERATIVE RADIOTHERAPY IN PROSTATE CANCER: REAL-WORLD-DATA

P-031 - AUTOMATIC PRESCRIPTION PLAN’S IMPLEMENTATION FOR RADIOTHERAPY QUALITY CONTROL IN MOSAIQ®

P-032 - BENIGN DISEASE AND RADIOTHERAPY IN A PUBLIC HOSPITAL, WHY NOT?

P-034 - BLADDER NECK PREDICTS URINARY TOXICITY IN ENDOMETRIAL CANCER TREATED BRACHYTHERAPY

P-035 - BOOST WITH INTRAOPERATIVE RADIOTHERAPY IN UNFAVORABLE BREAST CANCER MOLECULAR SUBTYPE

P-036 - Brachytherapy for vaginal intraepithelial neoplasia VaINIII

P-037 - BRACHYTHERAPY IN INOPERABLE ENDOMETRIAL CANCER

P-038 - BRACHYTHERAPY WITH LEIPZIG APPLICATOR IN NON-MELANOMA SKIN CANCER: FIRST RESULTS

P-039 - BRAIN METASTASES TREATED WITH RADIOSURGERY, ANALYSIS OF THE DOSE-TOXICITY-RESPONSE RELATIONSHIP

P-040 - BRIDGE RADIOTHERAPHY TO CAR-T THERAPY: CURRENT NECESSITY TO STANDARDIZE INDICATIONS

P-041 - CÁNCER DE MAMA TRATADO CON RADIOTERAPIA EN 5 SESIONES. CUIDADOS

P-042 - CARDIAC RADIOABLATION IN PATIENTS WITH REFRACTORY VENTRICULAR TACHYCARDIA